At Axon Integrative Health, were pioneers in neurological health and performance through the application of Methylene Blue IV therapy
Ozempic, Wegovy, Mounjaro, Zepbound - once positioned as diabetes and obesity innovations - are now being discussed in addiction clinics, neuroscientist labs, and policy circles for something far more consequential: the possibility that these drugs may blunt cravings for alcohol, nicotine, opioids, and other substances
Some effects appear to be direct, while others are likely secondary to weight loss and improved insulin sensitivity
One of the considerable factors to accelerate the market growth of glutathione is its increasing evidence of the potential benefits in different types of diseases
Cancer-associated fibroblasts in the single-cell era
But now